Explore All Access
Check if your research matches the topics covered in European Journal of Cancer, Supplement?
- Degree of match
- Common matching concepts
- Additional journal recommendations
European Journal of Cancer, Supplement : Impact Factor & More
eISSN: 1878-1217pISSN: 1359-6349
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
European Journal of Cancer, Supplement Key Metrics
CiteScore 
1.2
SNIP
0.2
European Journal of Cancer, Supplement Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 3000 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | European Organisation for Research and Treatment of Cancer (EORTC); European Association for Cancer Research (EACR); European CanCer Organisation (ECCO); European Society of Mastology (EUSOMA) |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in European Journal of Cancer, Supplement ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Journal of Cancer, Supplement
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
- 1 Nov 2021
- European Journal of Cancer Supplements
Editorial board
- 1 Nov 2021
- European Journal of Cancer Supplements
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
- 1 Nov 2021
- European Journal of Cancer Supplements
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
- 1 Nov 2021
- European Journal of Cancer Supplements
Insight updating of the molecular hallmarks in ovarian carcinoma
- 1 Aug 2020
- European Journal of Cancer Supplements
The hallmarks of ovarian cancer: proliferation and cell growth
- 1 Aug 2020
- European Journal of Cancer Supplements
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
- 1 Nov 2021
- European Journal of Cancer Supplements
Editorial board
- 1 Nov 2021
- European Journal of Cancer Supplements
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
- 1 Nov 2021
- European Journal of Cancer Supplements
Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
- 1 Nov 2021
- European Journal of Cancer Supplements
Insight updating of the molecular hallmarks in ovarian carcinoma
- 1 Aug 2020
- European Journal of Cancer Supplements
The hallmarks of ovarian cancer: proliferation and cell growth
- 1 Aug 2020
- European Journal of Cancer Supplements
FAQs on European Journal of Cancer, Supplement
How many articles did European Journal of Cancer, Supplement publish last year? 
In 2023, European Journal of Cancer, Supplement publsihed undefined articles.
What is the eISSN & pISSN for European Journal of Cancer, Supplement?
For European Journal of Cancer, Supplement, eISSN is 1878-1217 and pISSN is 1359-6349.
What is Citescore for European Journal of Cancer, Supplement?
Citescore for European Journal of Cancer, Supplement is 1.2.
What is SNIP score for European Journal of Cancer, Supplement?
SNIP score for European Journal of Cancer, Supplement is 0.2.
Who is the publisher of European Journal of Cancer, Supplement?
Elsevier is the publisher of European Journal of Cancer, Supplement.
